Omic Technologies in HIV: Searching Transcriptional Signatures Involved in Long-Term Non-Progressor and HIV Controller Phenotypes

by Erick De La Torre-Tarazona, Erick De La Torre-Tarazona, Rubén Ayala-Suárez, Rubén Ayala-Suárez, Rubén Ayala-Suárez, Francisco Díez-Fuertes, Francisco Díez-Fuertes, José Alcamí, José Alcamí, José Alcamí
Published 2022-07-01

Immune activation promotes evolutionary conservation of T-cell epitopes in HIV-1.

by Rafael Sanjuán, Miguel R Nebot, Joan B Peris, José Alcamí
Published 2013-01-01

Highly Efficient Autologous HIV-1 Isolation by Coculturing Macrophage With Enriched CD4+ T Cells From HIV-1 Patients

by Cristina Xufré, Tanía González, Tanía González, Lorna Leal, Lorna Leal, Charles M. Trubey, Jeffrey D. Lifson, José María Gatell, José Alcamí, José Alcamí, José Alcamí, Núria Climent, Núria Climent, Felipe García, Felipe García, Sonsoles Sánchez-Palomino, Sonsoles Sánchez-Palomino
Published 2022-04-01

Converging roads: the latest science from the 2017 IAS HIV Cure and Cancer Forum

by Genevieve E. Martin, José Alcami, Jean-Phillipe Spano, Anna Laura Ross
Published 2017-10-01

Heterogeneity in glycan composition on the surface of HIV-1 envelope determines virus sensitivity to lectins.

by Muzafar Jan, Chitra Upadhyay, José Alcami Pertejo, Catarina E Hioe, Sunil K Arora
Published 2018-01-01

High concentrations of Maraviroc do not alter immunological and metabolic parameters of CD4 T cells

by Erick De La Torre Tarazona, Caroline Passaes, Santiago Moreno, Asier Sáez-Cirión, José Alcamí
Published 2024-06-01

Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging

by Andrea Rodríguez-Agustín, Víctor Casanova, Judith Grau-Expósito, Sonsoles Sánchez-Palomino, José Alcamí, Núria Climent
Published 2023-03-01

Transcriptomic Evidence of the Immune Response Activation in Individuals With Limb Girdle Muscular Dystrophy Dominant 2 (LGMDD2) Contributes to Resistance to HIV-1 Infection

by Francisco Diez-Fuertes, Francisco Diez-Fuertes, María Rosa López-Huertas, María Rosa López-Huertas, Javier García-Pérez, Javier García-Pérez, Esther Calonge, Esther Calonge, Mercedes Bermejo, Mercedes Bermejo, Elena Mateos, Elena Mateos, Pilar Martí, Pilar Martí, Nuria Muelas, Nuria Muelas, Juan Jesús Vílchez, Juan Jesús Vílchez, Mayte Coiras, Mayte Coiras, José Alcamí, José Alcamí, José Alcamí, Sara Rodríguez-Mora, Sara Rodríguez-Mora
Published 2022-05-01

Impact of Transcriptome and Gut Microbiome on the Response of HIV-1 Infected Individuals to a Dendritic Cell-Based HIV Therapeutic Vaccine

by Roque Pastor-Ibáñez, Francisco Díez-Fuertes, Sonsoles Sánchez-Palomino, Jose Alcamí, Montserrat Plana, David Torrents, Lorna Leal, Felipe García
Published 2021-06-01

The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1

by María Rosa López-Huertas, Laura Jiménez-Tormo, Nadia Madrid-Elena, Carolina Gutiérrez, Sara Rodríguez-Mora, Mayte Coiras, José Alcamí, Santiago Moreno
Published 2017-05-01

Elite controllers long-term non progressors present improved survival and slower disease progression

by Laura Capa, Rubén Ayala-Suárez, Humberto Erick De La Torre Tarazona, Juan González-García, Jorge del Romero, José Alcamí, Francisco Díez-Fuertes
Published 2022-09-01

IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle

by Mayte Coiras, Mercedes Bermejo, Benjamin Descours, Elena Mateos, Javier García-Pérez, María-Rosa López-Huertas, Michael M. Lederman, Monsef Benkirane, José Alcamí
Published 2016-03-01

Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing.

by Marta Montes, Mayte Coiras, Soraya Becerra, Cristina Moreno-Castro, Elena Mateos, Jara Majuelos, F Javier Oliver, Cristina Hernández-Munain, José Alcamí, Carlos Suñé
Published 2015-01-01

Nucleic acid recognition and antiviral activity of 1,4-substituted terphenyl compounds mimicking all faces of the HIV-1 Rev protein positively-charged α-helix

by Cristina Medina-Trillo, Daniel M. Sedgwick, Lidia Herrera, Manuela Beltrán, Ángela Moreno, Pablo Barrio, Luis. M. Bedoya, José Alcamí, Santos Fustero, José Gallego
Published 2020-04-01

Insight in miRNome of Long-Term Non-Progressors and Elite Controllers Exposes Potential RNAi Role in Restraining HIV-1 Infection

by Rubén Ayala-Suárez, Francisco Díez-Fuertes, Esther Calonge, Humberto Erick De La Torre Tarazona, María Gracia-Ruíz de Alda, Laura Capa, José Alcamí
Published 2020-07-01

3-Phenylcoumarins as Inhibitors of HIV-1 Replication

by José Alcamí, Mahabir P. Gupta, Eduardo Muñoz, Esther del Olmo, José L. López-Pérez, Luis M. Bedoya, Rocío Sancho, Dionisio Olmedo, Arturo San Feliciano
Published 2012-08-01

Promiscuous, Multi-Target Lupane-Type Triterpenoids Inhibits Wild Type and Drug Resistant HIV-1 Replication Through the Interference With Several Targets

by Luis M. Bedoya, Luis M. Bedoya, Manuela Beltrán, Javier García-Pérez, Patricia Obregón-Calderón, Oliver Callies, Ignacio A. Jímenez, Isabel L. Bazzocchi, José Alcamí
Published 2018-04-01

Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors.

by Nuria González, Krisha McKee, Rebecca M Lynch, Ivelin S Georgiev, Laura Jimenez, Eulalia Grau, Eloísa Yuste, Peter D Kwong, John R Mascola, José Alcamí
Published 2018-01-01

Evolution of Serum Acute-Phase Glycoproteins Assessed by 1H-NMR in HIV Elite Controllers

by Ana-Irene Malo, Joaquim Peraire, Joaquim Peraire, Joaquim Peraire, Joaquim Peraire, Ezequiel Ruiz-Mateos, Jenifer Masip, Jenifer Masip, Jenifer Masip, Núria Amigó, Núria Amigó, Núria Amigó, José Alcamí, José Alcamí, José Alcamí, Santiago Moreno, Santiago Moreno, Josefa Girona, Josefa Girona, Josefa Girona, Graciano García-Pardo, Graciano García-Pardo, Graciano García-Pardo, Rosaura Reig, Francesc Vidal, Francesc Vidal, Francesc Vidal, Francesc Vidal, Antoni Castro, Antoni Castro, Antoni Castro, Lluís Masana, Lluís Masana, Lluís Masana, Lluís Masana, Anna Rull, Anna Rull, Anna Rull, Anna Rull
Published 2021-09-01

14 Treatment with tyrosine kinase inhibitors make PBMCs from patients with chronic myeloid leukemia less susceptible to HIV-1 infection: control of CD4+ T cell activation to contro...

by Mercedes Bermejo, Juan Ambrosioni, Guiomar Bautista, Núria Climent, Elena Mateos, Cristina Rovira, Rafael Duarte, Francisco Cervantes, Montserrat Plana, José M. Miró, José Alcamí, Mayte Coiras
Published 2017-07-01